CSIMarket
 

Healthcare Sector

Biotechnology & Pharmaceuticals Industry Profitability  


Profitability by Company within Biotechnology & Pharmaceuticals Industry


Company Quarter Gross Margin Net Margin Cash flow Margin ROE
Abcam Plc 4 Q 74.79% -2.35% 0% -
Acumen Pharmaceuticals Inc 1 Q - -371.36% -498.25% -22.87%
Atlantic Coastal Acquisition Corp Ii 4 Q - - - -
Aceragen Inc 1 Q - -885.3% -401.86% -215.27%
Achilles Therapeutics Plc 4 Q - - - -36.12%
Arcellx Inc 3 Q - -262.99% -1170.81% -48.49%
Acorda Therapeutics Inc 3 Q 87.78% -32.07% 26.09% -21.45%
Adaptimmune Therapeutics Plc 1 Q - -690.63% -49.68% -234.56%
Adma Biologics Inc 1 Q 48.22% 21.95% -7.43% -2.48%
Adaptive Biotechnologies Corporation 3 Q 48.98% -132.72% -54.14% -47.64%
Adverum Biotechnologies Inc 1 Q - - - -90.38%
Aerie Pharmaceuticals Inc 3 Q 80.82% -74.25% 40.55% -
Agenus Inc 3 Q 98.75% -265.41% -147.65% -
Applied Genetic Technologies Corporation 3 Q - - - -192.9%
Aim Immunotech Inc 4 Q 81.54% -19347.69% -15115.38% -118.26%
Avalon Globocare Corp 3 Q - -448.27% -94% -55.9%
Alector Inc 3 Q - -488.25% -324.72% -74.78%
Aligos Therapeutics Inc 3 Q - -556.99% -338.35% -104.34%
Allogene Therapeutics Inc 1 Q - -295454.55% -145981.82% -53.87%
Allena Pharmaceuticals Inc. 2 Q - - - -287.46%
Alvotech 4 Q - - - -
Allovir Inc 3 Q - - - -80.17%
Ambrx Biopharma Inc 3 Q - -43375.47% -5666.04% -67.63%
Amgen Inc 1 Q 57.03% -1.52% -16.6% 58.59%
Apogee Therapeutics inc 1 Q - - - -
Apeiron Capital Investment Corp 1 Q - - - -
Aptose Biosciences Inc 3 Q - - - -230.97%
Argenx se 4 Q 95.28% -11.83% 0% -7.2%
Armata Pharmaceuticals Inc 1 Q - -2590.17% - -
Athira Pharma Inc 3 Q - - - -61.33%
Atara Biotherapeutics Inc 3 Q - -1270.42% - -783.31%
Aura Biosciences Inc 3 Q - - - -40.83%
Autolus Therapeutics Plc 1 Q - -522.15% - -43.78%
Avrobio Inc 3 Q - - - -4.63%
Anavex Life Sciences Corp 1 Q - - - -29.04%
Axcella Health Inc 2 Q - - - -
Old Ayala Inc 4 Q 0% -9131.43% -57566.67% -308.79%
Bioatla Inc 3 Q - - - -89.27%
Biocardia Inc 1 Q - -4121.82% -280% -
Brainstorm Cell Therapeutics inc 1 Q - - - -
Biocryst Pharmaceuticals Inc 1 Q 98.64% -38.14% -28.37% -
Black Diamond Therapeutics Inc 1 Q - - - -72.94%
Beam Therapeutics Inc 3 Q - -558.88% -367.81% -40.66%
Biogen Inc 1 Q 76.33% 17.18% 2.08% 7.92%
Bluebird Bio Inc 3 Q 11.6% -578.85% 1.57% -34.32%
Biontech Se 4 Q 84.29% 24.36% 31.69% 4.6%
Zeo Scientifix Inc 1 Q 74.89% -123.7% -37.67% -
Cabaletta Bio Inc 3 Q - - - -47.05%
Candel Therapeutics Inc 3 Q - - - -90.47%
Cannabis Global Inc. 2 Q 1.47% -59.89% -44.25% -66.53%
C4 Therapeutics Inc 1 Q - -933.23% -1215.24% -52.85%
Codiak Biosciences Inc 3 Q - -3693.1% - -37.62%
Cidara Therapeutics Inc 1 Q - -122.01% -79.88% -
Creative Medical Technology Holdings Inc 1 Q - - - -46.49%
Cullinan Oncology Inc 3 Q - - - -31.5%
Compugen Ltd 4 Q 87% -449.25% 38.76% -43.38%
Cognition Therapeutics inc 1 Q - - - -98.65%
Chromocell Therapeutics Corporation 1 Q - - - -
Coherus Biosciences inc 1 Q 55.12% - - -
Calidi Biotherapeutics Inc 1 Q - - - -
Checkmate Pharmaceuticals Inc 1 Q - - - -83.92%
Compass Therapeutics Inc 1 Q - - - -28.67%
Coeptis Therapeutics Holdings Inc 1 Q - - - -441.32%
Caribou Biosciences Inc 1 Q - -1697.57% -72.54% -33.42%
Cardiff Oncology inc 1 Q - -885.15% -264.99% -52.35%
Cardiol Therapeutics inc 4 Q - - - -99.58%
Cargo Therapeutics Inc 3 Q - - - -
Curis Inc 1 Q - -569.32% - -224.75%
Crispr Therapeutics Ag 3 Q - - - -19.44%
Clarus Therapeutics Holdings Inc. 2 Q 71.36% -264.05% - -
Champions Oncology Inc 4 Q 34.7% -21.05% -8.69% -850.72%
Cel sci Corporation 1 Q - - - -218%
Cyclo Therapeutics Inc 1 Q 94.16% -2145.22% -3087.88% -2741.56%
Dbv Technologies S a 1 Q - -1943.5% -2831.7% -56.79%
Ginkgo Bioworks Holdings Inc 1 Q - -437.25% -269.79% -63.32%
Denali Therapeutics Inc 1 Q - - - 0.66%
Precision Biosciences Inc 3 Q - -61.58% -118.62% -179.63%
Dyadic International Inc 1 Q 56.98% -600.57% - -116.14%
Editas Medicine Inc 1 Q - -5458.15% -4795.15% -47.34%
Eiger Biopharmaceuticals Inc 4 Q - -353.77% -54.19% -869.84%
Elevation Oncology inc 1 Q - - - -59.35%
Eloxx Pharmaceuticals Inc 3 Q - - - -
Elutia Inc 1 Q 48.66% -307.96% -154.24% -
Entera Bio Ltd 1 Q - - - 103.4%
Enzon Pharmaceuticals inc 1 Q - 49.46% -158.27% 49.71%
Erytech Pharma S a 4 Q - - - -229.05%
Estrella Immunopharma Inc 4 Q - - - -117.69%
Evaxion Biotech A 4 Q - -30308.22% - -
Exelixis Inc 1 Q 95% 20.36% -0.81% 20.01%
Fate Therapeutics Inc 3 Q - -2323.56% -692.8% -38.44%
4d Molecular Therapeutics Inc 3 Q - -50.76% - -34.73%
Fennec Pharmaceuticals Inc 1 Q - 50.59% - -
Forma Therapeutics Holdings Inc. 2 Q - - - -39.68%
Finch Therapeutics Group Inc 3 Q - - - -220.02%
Freeline Therapeutics Holdings Plc 4 Q - - - -267.85%
Fresh Tracks Therapeutics Inc 4 Q - - - -58.8%
Fusion Pharmaceuticals Inc 3 Q - -860.02% -258.47% 44.47%
Agentix Corp 4 Q - - - -
Gilead Sciences Inc 1 Q 76.79% -62.37% -20.45% 2.19%
Monte Rosa Therapeutics Inc 3 Q - - - -58.2%
Gamida Cell Ltd 3 Q 6.98% - - -
Genocea Biosciences Inc 1 Q - -5917.78% -6300.37% -182.88%
Genfit S a 4 Q - -75.69% - -42.52%
Genenta Science S p a 4 Q - - - -57%
Green Planet Bioengineering Co Ltd 1 Q - - - -
Greenlight Biosciences Holdings Pbc 1 Q - -745.26% -933.43% -374.26%
Gritstone Bio Inc 3 Q - -2455.85% -835.14% -57.35%
Halozyme Therapeutics Inc 1 Q 85.54% 39.22% 23.62% 192.68%
Hillevax Inc 3 Q - - - -41.96%
Humacyte Inc 1 Q - -53160% - -306.81%
Immunitybio inc 1 Q - -335325% -331045% -
Icosavax Inc 3 Q - - - -43.06%
Ikena Oncology Inc 3 Q - -1463.54% - -42.27%
Inhibikase Therapeutics Inc 3 Q - -5775.11% - -94.66%
Immunocore Holdings Plc 1 Q 99.65% -34.66% - -
Immunovant Inc 1 Q - - - -56.11%
In8bio Inc 3 Q - - - -152.8%
Inhibrx Inc 1 Q - - - -678.51%
Mink Therapeutics Inc 3 Q - - - -
Inmune Bio Inc 3 Q - -19913.95% -13981.4% -52.26%
Intensity Therapeutics Inc 1 Q - - - -
Iovance Biotherapeutics inc 1 Q -915.52% -15800.84% -5692.31% -71.45%
Innate Pharma Sa 4 Q - -12.28% - -14.59%
Century Therapeutics inc 1 Q - -3282.11% -59.88% -64.37%
Iteos Therapeutics Inc 3 Q - - - -9.72%
Invivyd Inc 3 Q - - - -56.02%
Jounce Therapeutics inc 4 Q - -0.14% 89.59% -0.08%
Jasper Therapeutics Inc 3 Q - - - -66.86%
Kodiak Sciences Inc 3 Q - - - -73.87%
Kiromic Biopharma Inc 1 Q - - - -
Krystal Biotech Inc 1 Q - 2.06% 1.5% 7.65%
Kymera Therapeutics Inc 1 Q - -381.25% -148.07% -28.51%
Ladrx Corporation 1 Q - - - 207.75%
Lineage Cell Therapeutics Inc 3 Q 86.44% -574.48% - -33.17%
Lenz Therapeutics Inc 1 Q - - - -
Atyr Pharma Inc 3 Q - -3213.03% -706.52% -44.81%
La Jolla Pharmaceutical Company 2 Q 83.96% 23.31% 39.54% -
Logicbio Therapeutics Inc 3 Q - -212.55% -296.87% -115.29%
Lexeo Therapeutics Inc 3 Q - - - -
Mesoblast Ltd 2 Q - -1091.71% - -16.32%
Meiragtx Holdings Plc 1 Q - -2932.86% -1530.99% -62.36%
Miromatrix Medical inc 3 Q -1018.47% -57745.98% - -140.89%
Molecular Partners Ag 4 Q - -880.7% - -35.13%
Moderna Inc 1 Q 42.51% -703.59% -513.17% -41.83%
Mymetics Corporation 3 Q - -3276.47% -1000% -
Neurocrine Biosciences Inc 1 Q 98.54% 8.42% 28.18% 17.45%
Nkgen Biotech Inc 1 Q - -3871.94% 5.76% -
Neumora Therapeutics Inc 3 Q - - - -
Nanostring Technologies Inc 3 Q 36.19% -77.8% -43.32% -
Novavax inc 1 Q 36.91% -157.21% -93.63% -
Ocugen Inc 1 Q - -1175.94% -1290.63% -117.3%
Omega Therapeutics Inc 3 Q - -2677.26% -2860.29% -107.79%
Organovo Holdings Inc 3 Q - - - -129.61%
Opthea Limited 2 Q - -131469.74% - -
Orchard Therapeutics Plc 3 Q 72.31% -560.44% -234.91% -74.94%
Outlook Therapeutics Inc 1 Q - - - -
Oyster Point Pharma Inc 3 Q 75.89% -657.25% -646.34% -652.98%
Palisade Bio Inc 3 Q - - - -95.08%
Passage Bio Inc 1 Q - - - -68.53%
Phoenix Biotech Acquisition Corp 3 Q - - - -
Point Of Care Nano technology Inc 1 Q - - - -
Vaxcyte Inc 1 Q - - - -21.96%
Biomx Inc 1 Q - - - 496.46%
Peak Bio Inc 2 Q - - - -
Pluri Inc 1 Q - -7591.55% - -253.89%
Protalix Biotherapeutics inc 1 Q 30.58% -122.6% 95.38% 19.48%
Pharmacyte Biotech Inc 4 Q - - - -5.46%
Prime Medicine Inc 1 Q - -22.67% - -0.03%
Prokidney Corp 3 Q - - - -
Poseida Therapeutics Inc 3 Q - -339.8% -260.99% -87.41%
Polarityte Inc 4 Q - - - -43.88%
Mosaic Immunoengineering Inc 1 Q - - - -
Qiagen N v 4 Q 64.91% 17.96% 14.86% 8.96%
Qrons Inc 1 Q - - - -
Renovacor Inc 3 Q - - - -7.46%
Replicel Life Sciences Inc 4 Q - - - -
Replimune Group Inc 1 Q - - - -48.62%
Repligen Corp 3 Q 25.89% 12.87% 19.21% 5.93%
Regenxbio Inc 3 Q 57.16% -213.97% -53.8% -59.54%
Relay Therapeutics Inc 3 Q - -260.83% 21.53% -38.24%
Rubius Therapeutics Inc 4 Q - - - -254.93%
Revolution Medicines Inc 3 Q - - - -38.92%
Redwoods Acquisition Corp 3 Q - - - -
Recursion Pharmaceuticals Inc 1 Q 19.05% -662.41% -690.7% -79.96%
Sab Biotherapeutics Inc 3 Q - -402.59% -422.06% -120.36%
Sana Biotechnology Inc 3 Q - - - -65.36%
Scilex Holding Company 3 Q 66.47% -351.18% -327.63% -
Scinai Immunotherapeutics Ltd 4 Q - - - -
Seagen Inc 3 Q 74.52% -33.27% 18.48% -28.06%
Sangamo Therapeutics Inc 1 Q - -10205.61% - -258.23%
Solid Biosciences Inc 3 Q - - - -51.64%
Senti Biosciences Inc 1 Q - - - -73.92%
Sophia Genetics Sa 4 Q 69.31% -127.57% - -52.15%
Spk Acquisition Corp 3 Q -55.59% -77.82% -8.14% -
Sqz Biotechnologies Company 3 Q - - - 0%
Sorrento Therapeutics Inc 2 Q 56.31% -722.37% - -
Scholar Rock Holding Corp 1 Q - - - -94.2%
Surrozen Inc 3 Q - - - -58.26%
Sutro Biopharma Inc 3 Q - -291.21% -905.58% -103.03%
Surface Oncology Inc 2 Q - - - -111.71%
Springworks Therapeutics Inc 1 Q - - - -68.24%
Protara Therapeutics Inc 3 Q - - - -77.06%
Tarsus Pharmaceuticals Inc 1 Q 94.01% -129.39% -113.14% -71.12%
Tc Biopharm holdings Plc 4 Q - - - -213.13%
Tracon Pharmaceuticals Inc 3 Q - - - -
Tcr2 Therapeutics Inc 1 Q - - - -97.81%
Tscan Therapeutics Inc 3 Q - -591.64% -1380.22% -65.79%
Bio techne Corp 4 Q 64.78% 10.08% -6.8% 11.47%
Instil Bio Inc 1 Q - - - -63.95%
Tenaya Therapeutics Inc 3 Q - - - -62.76%
Tourmaline Bio Inc 1 Q - - - -15.49%
Turnstone Biologics Corp 3 Q - - - -
Taysha Gene Therapies Inc 3 Q - -2467.07% - -
Titan Pharmaceuticals Inc 1 Q - - - -99.94%
Tevogen Bio Holdings Inc 4 Q - - - -
Twist Bioscience Corporation 1 Q 41.01% -60.41% -30.41% -31.61%
Valneva Se 4 Q 34.37% -65.99% - -79.09%
Vericel Corporation 1 Q 68.94% -7.53% -31.44% 0.21%
10x Capital Venture Acquisition Corp Iii 3 Q - - - -
Vectivbio Holding Ag 4 Q - -342.84% - -43.93%
Vigil Neuroscience Inc 3 Q - - - -48.56%
Vir Biotechnology Inc 1 Q 99.9% -115.79% -143.36% -32.58%
Vor Biopharma Inc 3 Q - - - -53.72%
Vaxart Inc 1 Q - -1119.53% -367.72% -121.06%
Voyager Therapeutics Inc 1 Q - -58.05% - -1.28%
Windtree Therapeutics Inc 1 Q - - - -62.91%
X4 Pharmaceuticals Inc 1 Q - - - -284.93%
Xtant Medical Holdings Inc 4 Q 59.65% -14.98% -9.84% 1.56%
Zivo Bioscience Inc 1 Q 35% -3579.19% -380.01% -
Zura Bio Limited 1 Q - - - -26.38%
Profitability
Biotechnology & Pharmaceuticals Industry
Gross margin improved to 73.53 % in 1. Quarter 2024 from 68.84 % in previous quarter, now Ranking #24 and ranking within sector #2.


More on Biotechnology & Pharmaceuticals Industry Profitability



More on Biotechnology & Pharmaceuticals Industry Cash flow
More on Biotechnology & Pharmaceuticals Industry ROE












Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com